These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2080916)

  • 1. Antitumor activity of L-asparaginase from Cylindrocarpon obtusisporum MB-10 and its effect on the immune system.
    Raha SK; Dey SK; Roy SK; Chaudhuri S; Chakrabarty SL
    Biochem Int; 1990 Sep; 21(6):1001-11. PubMed ID: 2080916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Vibrio cholerae-L-asparaginase on surface structure of splenic lymphocytes.
    Dey SK; Sinha A; Roy SK; Chakrabarty SL
    Indian J Med Res; 1992 Nov; 95():288-93. PubMed ID: 1291463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of an L-asparaginase from Cylindrocarpon obtusisporum MB-10.
    Raha SK; Roy SK; Dey SK; Chakrabarty SL
    Biochem Int; 1990 Sep; 21(6):987-1000. PubMed ID: 2080924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent.
    Poznansky MJ; Shandling M; Salkie MA; Elliott JF; Lau E
    Cancer Res; 1982 Mar; 42(3):1020-5. PubMed ID: 6895861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune rejection of tumors by protein A in mice bearing transplantable solid tissue Dalton's lymphoma tumors.
    Dwivedi PD; Verma AS; Ray PK
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):105-28. PubMed ID: 1597651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the immunosuppressive and anti-inflammatory action of L-asparaginase.
    Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):243-7. PubMed ID: 776121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Binding of the antileukemia drug Escherichia coli L-asparaginase to the plasma membrane of normal human mononuclear cells].
    Mercado-Vianco L; Arenas-Díaz G
    Sangre (Barc); 1999 Jun; 44(3):204-9. PubMed ID: 10481582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of cisplatin against murine ascites Dalton's lymphoma.
    Prasad SB; Giri A
    Indian J Exp Biol; 1994 Mar; 32(3):155-62. PubMed ID: 8070834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
    Bhutia SK; Mallick SK; Maiti S; Maiti TK
    Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Ajith TA; Anu V; Riji T
    J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique.
    Kops SK; Ratzlaff RE; Meade R; Iverson GM; Askenase PW
    J Immunol; 1986 Jun; 136(12):4515-24. PubMed ID: 2423595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the potential immunotoxicity of 3-monochloro-1,2-propanediol in Balb/c mice. I. Effect on antibody forming cell, mitogen-stimulated lymphocyte proliferation, splenic subset, and natural killer cell activity.
    Lee JK; Byun JA; Park SH; Kim HS; Park JH; Eom JH; Oh HY
    Toxicology; 2004 Nov; 204(1):1-11. PubMed ID: 15369844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Anderson AJ; Holcenberg JS
    Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.